Asthma
COPD
Pulmonary
COPD: Page 21
ATS 2024: Study takes race out of the equation
Spirometry clinical trial eligibility may differ with race-neutral equations.
May 23, 2024
Tezspire shows promising potential for COPD treatment
Results from the phase 2a COURSE trial provide insight into the impact on COPD exacerbations.
May 23, 2024
Start-up aims to develop drugs for immunology and inflammation
Three hundred million in financing will go toward clinical trials for COPD and asthma treatments.
May 17, 2024
Sponsored
Pulmonary fibrosis insight
Ascend Media
The 2026 report provides global pipeline therapies in various clinical trial stages.
August 10, 2026
COPD: A public health issue in rural communities
The CDC says rural residents face higher risks from COPD.
May 17, 2024
Lung abnormality progression linked to acute respiratory disease in smokers
Quantitative interstitial abnormalities may be a precursor to emphysema.
May 9, 2024
FTC challenges patents said to block competition
The disputes include more than 300 junk listings of drugs used for common conditions, including COPD and asthma.
May 9, 2024
Sponsored
CDC vaccine schedules
Ascend Media
View the most recent vaccine recommendations for infants, young children and teens.
July 21, 2026
Plant-based diet decreases risk of developing emphysema
New research shows a nutritionally rich diet reduced incidences of chronic lung disease.
May 1, 2024
Grant money aimed at studying wearable biosensors
The proposed sensor could revolutionize COPD management with new method for predicting acute exacerbations.
May 1, 2024
Ultra-processed foods pose risk for respiratory diseases
A diet high in these foods significantly increases the risk of death from chronic respiratory diseases.
April 25, 2024
Sponsored
Pulmonary drug market forecast
Ascend Media
Review analysis, trends and predictions for pulmonary drug delivery systems, 2026 to 2035.
July 21, 2026
COPD Foundation releases guidelines on infection risk during nebulization
Recommendations focus on mitigating risk in both health care settings and home environments.
April 25, 2024
Phase 3 trial in development for tezepelumab in COPD
The announcement comes after encouraging results in Amgen’s phase 2a trial.
April 19, 2024
FDA-approved smart inhaler now available
Enhanced monitoring device is compatible with asthma and COPD inhalers.
April 19, 2024
Previous Page
Page 21 of 27
Next Page
Most Popular
Hidden immune cell unlocks novel SCLC treatment approach
Long-term impact of pediatric TB patients
Primary care initiative tackles asthma rescue inhaler overuse
Mepolizumab reduces systemic corticosteroid exposure in COPD patients
The overlooked burden of comorbidities in severe asthma care
COPD treatment falls short in phase 2 proof-of-concept trial